Meriel Owen, PhD, is a member of the ADDF's Scientific Affairs team. She supports the scientific portfolio through strategic review and program management.

“We’re humbled to have been hosted by Bakar Labs,” said Meriel Owen, PhD, associate director of search and evaluation at the Alzheimer’s Drug Discovery Foundation. “We had an amazing event today that featured the biology of aging and Alzheimer’s disease, therapeutic approaches and biomarker development.

Meriel OWEN, PhD | Cited by 166 | of Northwestern University, IL (NU) | Read 9 publications | Contact Meriel OWEN

We demonstrate that individuals with the greatest UE synergy severity and hand impairments poststroke have the highest FA in the CL RetST a pattern consistent with increased myelination and suggestive of neuroplastic reorganization.

Meriel Owen’s Post Meriel Owen Director, Search & Evaluation 1y Report this post This is a great opportunity for academic scientists working on new drugs for dementia. Feel free to reach out if ...

Meriel Owen, PhD Associate Director, Search & Evaluation at Alzheimer's Drug Discovery Foundation 1y Report this post To all investors in the dementia space or those interested in it: this is a ...

Meriel Owen is the Director at Alzheimer's Drug Discovery Foundation. Meriel Owen is the Board Member at CuriOdyssey. There is no recent news or activity for this profile.

Information on current and former positions, network members and contacts for Meriel Owen. Use the PitchBook Platform to explore the full profile.

Meriel Owen, PhD Associate Director, Search & Evaluation at Alzheimer's Drug Discovery Foundation 7 meses Denunciar esta publicación I will be attending #BIO2023 in Boston June 5-8 on behalf of the @Alzheimer’s Drug Discovery Foundation. We look forward to meeting and partnering with ...